ISPC vs PODD · rev $9.3M vs P/E 34, rev $2.07B
iSpecimen Inc (ISPC) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ISPC currently screens at market cap $4.4M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ISPC and PODD stock pages for the full models.
Not investment advice.